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CONTINUING ADIPOBIOLOGY EDUCATION (CAE)
Here, we introduce in Adipobiology a new section termed Con-
tinuing Adipobiology Education (CAE), a form of “classical” 
Continuing Medical Education (CME). We will present “scaf-
folding” - a metaphor that describes the way a teacher provides 
assistance to the students during the learning process in much 
the same way that the construction scaffolding serves as a tem-
porary support until the building can stand on its own, which, in 
terms of neurocognition, is conceptualized as scaffolding theory 
of aging and cognition (1,2).
Today, a plethora of publications is disseminating globally. 
In a “think globally-act locally” manner, each of us, mostly in 
a group with others, focuses on her/his research topic. “It is our 
view that this has brought us only from stage 1 to stage 2 in terms 
of the three stages of knowledge presented by our Zen epigraph” 
written by the great scientist Oscar Hechter (3). First expressed 
in 1964, it sounds true also today. We – teachers, researchers and 
“To a man who knows nothing, 
Mountains are mountains
Water is water and
Trees are trees.
When he has studied and knows a little, 
Mountains are no longer mountains
Water is no longer water and
Trees are no longer trees.
When he has thoroughly understood,
Mountains are again mountains
Water is water and
Trees are trees.”
students - are, nevertheless, a curious entity. Hence, to further 
move on the route of fascination with the different aspects of 
biomedical science, “we have some suggestions to offer regard-
ing routes to stage 3” (3), presenting two Scaffolding entitled (i) 
Neuroadipology, and (ii) Tunica adiposa, as constructed by the 
Editor-in-Chief. 
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SCAFFOLDING 1: NEUROADIPOLOGY
High fat/high caloric consumption and sedentary life are linked 
to the initiation and development obes ity and related diseases. 
Arguably, we are learning more about the molecular mecha-
nisms controlling food intake and energy homeostasis, in which 
the adipose tissue-brain crosstalk is an important player. In the 
last 15 years, studies in the field of adipobiology have enjoyed 
explosive growth, demonstrating that the adipose tissue is the 
body’s largest endocrine and paracrine organ producing numer-
ous signaling proteins collectively designated adipokines (1-3). 
The most momentous changes that have occurred in these stud-
ies have been the discovery of leptin in 1994, and its role in regu-
lating energy homeostasis (4) as well as memory and learning 
(5). 
Both WAT and BAT (white and brown adipose tissue, re-
spectively) are morphological and functional expressions of a 
dynamic system, consisting of adipocytes and non-adipocytes 
(stromal, vascular, nerve and immune cells). Adipose tissue-
derived cells have the ability to differentiate into several lineages 
including neuronal cells (6, also see Tonchev et al in this volume 
of Adipobiology). Adipose tissue is also located in cavernous 
sinus/parasellar region of the brain (7). In effect, adipobiology 
became an arena of many “white” (and “brown”) novelties: (i) 
new functions (e.g., endo-, para-, auto- and intracrine secretion, 
inflammation, neuroprotection) (8-16), (ii) new molecules (adi-
pokines, lipid droplet-associated proteins, nitric oxide, hydro-
gen sulfide), and (iii) new implications in the pathogenesis of a 
variety of diseases (8). 
The present Scaffolding highlights current data of adipose-
derived neuropeptides, neurotrophic factors, pituitary hor-
mones, hypothalamic releasing factors, and neurotransmitters. 
And propose that adipose tissue may be a member of the dif-
fuse neuroendocrine system (DNES). Altogether this is concep-
tualized as neuroadipology, a new example for a link between 
neurobiology and other topics, such as neuroimmunology, neu-
roendocrinology and neurogastroenterology. 
Historically, Nikolai Konstantinovich Kulchitsky (1856-1925) 
has identified the enterochromaffin cells found in the crypts of 
Lieberkuhn of gastrointenstinal mucosa, in 1897. This discovery 
Ask yourself for each of your thoughts: is it a new one?
Carl Gustav Jung (1875-1961) 
formed the basis for the subsequent delineation of the DNES by 
Friedrich Feyrter in 1938; examples of DNES include Feyrter’s 
Hellen Zellen (clear cells) in pancreas and gut, hepatic stellate 
cells (Ito cells) and other cells disseminated throughout the body 
(12 and references therein). Proudworthy, my classmate, Michail 
Davidoff, has innovatively contributed to the neuroendocrine 
nature of testicular Leydig cells (17).
While numerous studies have demonstrated that brain can 
control adipose tissue functions, it is only now becoming ap-
parent that the control is bidirectional, that is, the adipose tissue 
can affect brain functions. For instance, (i) many neuropeptides 
and neurotrophic factors and their receptors are shared by the 
adipose tissue and brain (13,14), (ii) most pituitary hormones 
and hypothalamic releasing factors, termed “adipotrophins”, 
are expressed in adipose tissue (15), and (iii) the adipokines 
leptin, adiponectin, resistin and fasting-induced adipose fac-
tor (angiopoietin-like protein 4) and their receptors are found 
in the brain (12). While nerve growth factor (NGF), discovered 
by the Nobel laureate Rita Levi-Montalcini, was found in largest 
amount in the mouse submandibular glands, it appears today 
that the adipose tissue may also be a major biological source of 
NGF and other neurotrophic factors, such as brain-derived neu-
rotrophic factor (13-15), metallothioneins, and neuroprotectin 
D, a derivative of decosahexaenoic acid, an essential fatty acid 
(16). Altogether, the possible neuroendocrine potential of adi-
pose tissue is illustrated in Tables 1 and 2, suggesting adipose tis-
sue membership in DNES. 
Does our adipose tissue tell our brain what to do?
Today (dnes, in Bulgarian), adipose tissue is “getting nervous” 
(18). Metaphorically, this talented tissue is increasing dramati-
cally its intelligence quotient (IQ) (6). As well as the gut is con-
sidered a second brain, the adipose tissue may likely function as 
a third brain (12). 
In 1999, Albee Messing has published Editorial entitled “Nes-
tin in the Liver – Lessons from the Brain” (Hepatology 1999; 29: 
602-603). He wrote therein: “Most neuroscientists manage to get 
through each day without thinking of the liver even once… but 
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I think that is about to change.” This may also be the case for 
adipose tissue. And a step forward but not the whole journey 
into neophilia, herein designated neuroadipology, a novel com-
ponent of neuroendocrinology (19).
In the preparation of this Scaffolding as well as our review 
published in Cell Biology International (19), I have had the co-
operation of my colleague-friends Michail Davidoff (Hamburg, 
Germany), Anton Tonchev (Varna, Bulgaria), Marco Fiore and 
Luigi Aloe (Rome, Italy), and Maria Staykova (Canberra, Aus-
tralia). If the Scaffolding has positive features suggesting new 
field in connecting adipose and neural tissue, these should be 
regarded as the results of the collaborative dialogue between my 
colleague-friends and myself. I retain responsibility for all defi-
ciencies present. 
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Table 1. Neuroendocrine factors in adipose tissue
Neuropeptides
Agouti protein, Neuropeptide tyrosine (NPY),  
Calcitonin gene-related peptide 




Nerve growth factor, Brain-derived neurotrophic factor, Leptin 
Ciliary neurotrophic factor, Glial cell line-derived neurotrophic 
factor 
Insulin-like growth factor 1, 2, Angiopoietin-1,  
Vascular endothelial growth factor 
Hypothalamic factors 
Mineralocorticoid-releasing factors 
Corticotropin-releasing hormone (CRH) 
Stresscopin, Urocortin (CRH-like peptides) 
From reference 19.
Table 2. Neural and neuroendocrine markers in adipose tis-
sue
Semaphorin (Sema3A), Neuropilin-1, Pantophysin 
Neuronal nuclear antigen, Nestin, Neuron-specific enolase 
Glial fibrillary acidic protein, Vimentin, Stathmin-like 2 
NF70, S100, Musashi-1 genes, Beta3 tubulin 
Acetylcholinesterase and choline acetyltransferase 
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Recently, obesity and related cardiometabolic diseases are among 
the major physical, social and economic burdens, globally. The 
World Health Organization has predicted a “globesity epidemic” 
with more than one billion adults being overweight (BMI over 
25 kg/m2) and at least 400 million of these being clinically obese 
(BMI over 30 kg/m2). Arguably, we have learned more about the 
molecular control of food intake and energy homeostasis, par-
ticularly, the role played by adipose tissue in the pathogenesis 
of various diseases, including cardiometabolic diseases (athero-
sclerosis, hypertension, obesity, type 2 diabetes mellitus, meta-
bolic syndrome). 
A long standing paradigm holds that the vascular wall con-
sists of three coats: tunica intima, t. media, and t. adventitia. 
However, a paradigm shift comes of age: adipose tissue can ex-
press not only lipid-storage, but also secretory phenotype, par-
ticularly in the adipobiology of disease (Curr Pharm Des 2003; 
9: 1023-1031). Hence we have forwarded the following message: 
“to further elucidate the potential role of periadventitial adipose 
tissue (PAAT) in atherosclerosis, we should no longer, as hith-
erto, cut it from the artery wall, but keep it attached and in place, 
SCAFFOLDING 2: TUNICA ADIPOSA
…two roads diverged in a wood, and I - 
I took the one less traveled by, 
And that has made all the difference.
Robert Frost, from The road not taken 
and subject to thorough examination” (Int Med J 2000; 7: 43-
49; Atherosclerosis 2001; 154: 237-238). We thus conceptualized 
that the PAAT may indeed be the forth, outermost vascular coat, 
hence, tunica adiposa (Ser J Exp Clin Res 2008; 9: 81-88; Obes 
Metab 2010; 6: 46-49). Figure 1 presents a schematic illustration 
of vascular wall.
In 1983 at the seminar at the Department of Anatomy, Uni-
versity of Chicago Medical School, Chicago, IL, I delivered a lec-
ture about secretion in vascular smooth muscle cells, a key cell 
type implicated in atherogenesis. During the discussion, a ques-
tion whether adventitial fibroblasts may migrate into the intima 
was raised. The answer of the lecturer was “I do not know. It 
seems impossible”. However, what seemed “impossible” in 1983 
was proven possible in 1996 (1) and later extended “outward” to 
PAAT (2-12).
Atherosclerosis, with its manifestation coronary artery dis-
ease, is the major cause of morbidity and mortality, globally. In 
atherogenesis, the response-to-injury paradigm of Russell Ross 
(N Engl J Med 1999; 340: 115-126) is not yet shifted, but sig-
nificantly enriched. It proposes that lymphocyte and monocyte 
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extravasation into the intima and vascular smooth muscle cell 
proliferation and oversecretion of matrix molecules are the key 
events in the development of atherosclerotic plaques. Because 
advanced intimal lesions lead to luminal loss, resulting in infarc-
tion, the intima is considered the most important vascular area 
involved in atherogenesis. However, it is unlikely that a single, 
linear pathway can mediate such a multiplex pathological proc-
ess. Arguably, an interactive approach targeting all structural 
components of the vascular wall is required. 
As indicated above, an extensive body of work has revealed 
that adipose tissue expresses not only metabolic, but also endo-, 
auto-, and paracrine/“vasocrine” (4) activity (Fig. 2). This new 
biology is achieved through secretion of more than 100 highly 
active signaling proteins, collectively termed adipokines (13-
21), abundantly secreted by inflamed adipose tissue.
One aspect of the role of tunica adiposa is whether it facilitates 
or inhibits the process of atherogenesis. It is know that the proxi-
mal segments of coronary arteries are surrounded by (sub)epi-
cardial adipose tissue (EAT), and these are atherosclerosis-prone 
as compared to the distal, intramyocardial, tunica adiposa-free, 
atherosclerosis-resistant coronaries (20). However, when EAT are 
totally absent, as in congenital generalized lipodystrophy, coro-
nary atherosclerosis can still occur, suggesting that a homeostatic 
presence of adipose tissue is required for coronary artery health. 
Given the key role of inflammation in the development of 
atherosclerotic lesions, what role might tunica adiposa play in 
the process of atherogenesis (Fig. 3)? The expansion of adipose 
tissue seen in obesity is associated with an imbalanced secretion 
represented by an enhanced release of proinflammatory adipok-
ines and by decreased release of anti-inflammatory adipokines 
(Table 1). Such an “enemy-or-friend” secretory capacity of tu-
nica adiposa requires specific pharmacological manipulation, 
aiming at boosting the production and/or receptor sensitivity of 
anti-inflammatory adipokines. Further, recent evidence shows 
that plasma and tissue levels of the neurotrophins nerve growth 
factor (NGF) and brain-derived neurotrophic factor (BDNF), 
which are also produced by adipose tissue (16), are altered in 
coronary atherosclerosis and metabolic syndrome (20). 
“So what does it mean if ” (18) adipoparacrinology is indeed 
a biological rational in cardiovascular health and disease? First, 
in basic research, as indicated above, we should no longer cut 
tunica adiposa, but keep it attached and in place, and subject 
to thorough examination. Second, echocardiography, compu-
ter tomography, magnetic resonance imaging and other imag-
ing technologies of heart-associated adipose tissue may identify 
high-risk population susceptible to atherosclerosis, and monitor 
vascular wall changes during follow-up studies and therapeutic 
trials (22-24). Third, tunica adiposa and, in general, heart-asso-
ciated adipose tissue may represent a new therapeutic target in 
cardiovascular disease (6,9,16). 
Figure 1. Schematic illustration of 
four-coated composition of the vas-
cular wall. EDRF, endothelium-derived 
relaxing factor. ADRF, adipose-derived 
relaxing factor. From reference 11. 
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Yudkin et al., Lancet 2005
Human Coronary Atherosclerosis
Figure 2. Schemantic 
illustration of vascular 
wall, including perivas-
cular adipocyte and 
respective “vasocrine” 
signaling (red arrow). 
From reference 4.





and tunica adiposa 
(above) are enlarged. 
From reference 20.
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Take brain message
Here I have “scaffolded” an adipose road in vascular biology, 
focusing on the possible paracrine role of tunica adiposa in an 
“outside-in” signaling related to atherosclerosis. 
Traditional concept of atherogenesis focuses on the intimal 
road, where “inside-out” inflammatory processes and endothe-
lial dysfunction trigger atherosclerotic plaque formation. Here 
we took the adipose road, which is less traveled.
Until recently, physicians have looked upon obesity as accu-
mulation of external adipose tissue. This was routinely evalu-
ated by various anthropometic measurements including BMI 
and waist, hip and, recently, neck circumference. However, re-
cent non-invasive techniques, such as echography, computed 
tomography, MRI and positron emission tomography, reveal a 
new picture of adipose distribution. Hence, we should appreci-
ated not only anthropometric values of external adipose tissue, 
but – more importantly - the “weight” of internal adipose tissue, 
particularly, tunica adiposa as well as epicardial and pericardial 
adipose tissue, in cardiovascular disease.
“And that has made some difference”, paraphrasing Robert 
Frost’s The road not taken.
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as related to cardiovascular disease
Pro-inflammatory adipokines
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Anti-inflammatory and metabotrophic adipokines
Adiponectin, IL-1 receptor antagonist, IL-10, metallothioneins, 
NGF, BDNF, TGF-β, cardiac natriuretic peptide, adrenomedul-
lin, angiopoietin-like protein 4
Vasodilators
Adipocyte-derived relaxing factor, nitric oxide (NO), hydro-
gen sulfide (H2S)**, adiponectin, cardiac natriuretic peptide, 
adrenomedullin
Vasoconstrictors
Superoxide anion, angiotensin II, endothelin-1
* Today, hyperhomocysteinemia is in the list of global cardi-
ometabolic risks. This sulfur-containing aminoacid deriving 
from the metabolism of methionine may also be consider 
“adipokine” - all enzymes involved in the synthesis and me-
tabolism of homocyteine are expressed in adipose tissue, 
suggesting that adipose tissue may be an important source 
of circulating homocysteine (19).
** See Bełtowski et al in this volume of Adipobiology. This photograph was taken by Nick Chaldakov in 1994. From 
left-to-right, Anton Tonchev, MD, PhD, now Associate Professor 
of Anatomy and Histology, Medical University, Varna, Bulgraia; 
Wale Sulaiman, MD, PhD, FRCS, now Head of Department of 
Neurosurgery, Ochsner Medical Center, New Orleans, LA, USA; 
George Chaldakov; Rouzha Pancheva, MD, PhD (and, more im-
portantly, mother of three kids), now Assistant Professor, De-
partment of Pediatrics, University St Mariana Hospital, Varna, 
Bulgaria, and Kamen Vachanov, MD, Consultant, Department 
of Anaesthesia, Papworth Hospital, Cambridge, UK. 
References
1.  Shi Y, O’Brien JE, Fard A, Mannion JD, Wang D, Zalewski 
A. Adventitial myofibroblasts contribute to neointimal for-
mation in injured porcine coronary arteries. Circulation 
1996; 94: 1655-1664.
2.  Stankulov IS, Aloe L, Ghenev PI, Manni L, Pavlov P, Fiore M, 
et al. PAAT: a path to atherosclerosis? Biomed Rev 2002; 13: 
63-65.
3.  Gollasch M, Dubrovska G. Paracrine role for periadventi-
tial adipose tissue in the regulation of arterial tone. Trends 
Adipobiology 2, 2010
85
Pharmacol Sci 2004; 25: 647-653.
4.  Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signalling 
from perivascular fat: a mechanism linking insulin resist-
ance to vascular disease. Lancet 2005;365:1817–1820.
5.  Fesüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, 
Luft FC, et al. Adiponectin is a novel humoral vasodilator. 
Cardiovasc Res 2007; 75: 719-727. 
6.  Chaldakov GN. Cardiovascular adipobiology: a novel. 
Heart-associated adipose tissue in cardiovascular disease. 
Ser J Exp Clin Res 2008; 9: 81-88.
7.  Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, 
Tabata Y, et al. Periadventitial adipose tissue plays a critical 
role in vascular remodeling. Circ Res 2009;105:906-911.
8.  Sacks HS, Johnson E. Adipokine concentrations are simi-
lar in femoral artery and coronary venous sinus blood: evi-
dence against in vivo endocrine secretion by human epicar-
dial fat. Adipobiology 2009; 1: 51-56.
9.  Lu C, Su LY, Lee RM, Gao YJ. Mechanisms for perivascular 
adipose tissue-mediated potentiation of vascular contraction 
to perivascular neuronal stimulation: the role of adipocyte-
derived angiotensin II. Eur J Pharmacol 2010; 634: 107-112.
10.  Rajsheker S, Manka D, Blomkalns AL, Chaatterjee TK, Stoll 
LL, Weintraub NL. Crosstalk between perivascular adipose 
tissue and blood vessels. Curr Opin Pharmacol 2010; 10: 
191-196.
11.  Chaldakov GN, Fiore M, Rancic G, Ghenev PI, Tuncel N, 
Beltowski J, et al. Rethinking vascular wall: periadventitial 
adipose tissue (tunica adiposa). Obes Metab 2010; 6: 46-49. 
12.  Ma L, Ma S, He H, Yang D, Chen X, Luo Z, et al. Perivascular 
fat-mediated vascular dysfunction and remodeling through 
the AMPK/mTOR pathway in high-fat diet-induced obese 
rats. Hypertens Res 2010 February 26. In print.
13.  Renes J, Rosenow A, Mariman E. Novel adipocyte features 
discovered by adipoproteomics. Adipobiology 2009; 1: 7-18. 
14.  Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan 
AK, Chemma PS. Human epicardial adipokine messenger 
RNAs: comparison of their expression in substernal, sub-
cutaneous, and omental fat. Metabol Clin Exp 2010; doi: 
10.1016/j.metabol.2009.12.027
15.  Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. 
Adipokines in periaortic and epicardial adipose tissue: Dif-
ferential expression and relation to atherosclerosis. J Athero-
scler Thromb 2010; 17: 115-130.
16.  Töre F, Tonchev AB, Fiore M, Tuncel N, Atanassova P, Aloe 
L, et al. From adipose tissue protein secretion to adipop-
harmacology of disease. Immunol Endocr Metab Agents Med 
Chem 2007; 7: 149-155. 
17.  Sornelli F, Fiore M, Chaldakov GN, Aloe L. Brain-derived 
neurotrophic factor: a new adipokine. Biomed Rev 2007; 18: 
65-68.
18.  Sacks HS. Weight loss in obesity reduces epicardial fat thick-
ness; so what? J Appl Physiol 2009; 106: 1-2.
19.  Bełtowski J, Tokarzewska D. Adipose tissue and homo-
cysteine metabolism. Biomed Rev 2009; 20: 1-11. 
20.  Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova 
MG, Antonelli A, et al. Neurotrophin presence in human 
coronary atherosclerosis and metabolic syndrome: a role for 
NGF and BDNF in cardiovascular disease? Prog Brain Res 
2004; 146: 279-289.
21.  Karastergiou K, Evans L, Ogston N, Miheisi N, Nair D, 
Kaski JC, et al. Epicardial adipokines in obesity and coro-
nary artery disease induce atherogenic changes in mono-
cytes and endothelial cells. Arterioscler Thromb Vasc Biol 
2010; 30:1340-1346.
22. Brinkley TE, Hsu FC, Carr JJ, Hundley WG, Bluemke DA, 
Polak JF, et al. Pericardial fat is associated with carotid stiff-
ness in the Multi-Ethnic Study of Atherosclerosis. Nutr Me-
tab Cardiovasc Dis 2010 Feb 11 (in press).
23.  Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O’Donnell 
CJ, Fox CS, et al. Novel measurements of periaortic adi-
pose tissue in comparison to anthropometric measures of 
obesity, and abdominal adipose tissue. Int J Obes (Lond) 
2009;33:226-232. 
24. Skilton MR, Sérusclat A, Sethu AH, Brun S, Bernard S, 
Balkau B, et al. Noninvasive measurement of carotid extra-
media thickness: associations with cardiovascular risk fac-
tors and intima-media thickness. JACC Cardiovasc Imaging 
2009;2:176-182.
